Publikationen von de la Fuente, Josu

Lüftinger, Roswitha, Zubarovskaya, Natalia, Galimard, Jacques-Emmanuel, Cseh, Annamaria, Salzer, Elisabeth, Locatelli, Franco, Algeri, Mattia , Yesilipek, Akif, de la Fuente, Josu, Isgrò, Antonella, Alseraihy, Amal, Angelucci, Emanuele, Smiers, Frans J., La La Nasa, Giorgia, Zecca, Marco , Fisgin, Tunc, Unal, Emel, Kleinschmidt, Katharina, Peters, Christina, Lankester, Arjan und Corbacioglu, Selim (2022) Busulfan–fludarabine- or treosulfan–fludarabine-based myeloablative conditioning for children with thalassemia major. Annals of Hematology 101 (3), S. 655-665. Volltext nicht vorhanden.

Frangoul, Haydar, Altshuler, David, Cappellini, M. Domenica, Chen, Yi-Shan, Domm, Jennifer, Eustace, Brenda K., Foell, Juergen, de la Fuente, Josu, Grupp, Stephan, Handgretinger, Rupert, Ho, Tony W. , Kattamis, Antonis, Kernytsky, Andrew, Lekstrom-Himes, Julie, Li, Amanda M., Locatelli, Franco, Mapara, Markus Y., de Montalembert, Mariane, Rondelli, Damiano, Sharma, Akshay , Sheth, Sujit, Soni, Sandeep, Steinberg, Martin H., Wall, Donna, Yen, Angela und Corbacioglu, Selim (2021) CRISPR-Cas9 Gene Editing for Sickle Cell Disease and β-Thalassemia. New England Journal of Medicine 384 (3), S. 252-260. Volltext nicht vorhanden.

Iqbal, Madiha, Reljic, Tea, Corbacioglu, Selim, de la Fuente, Josu, Gluckman, Eliane, Kumar, Ambuj, Yassine, Farah, Ayala, Ernesto, El-Jawahri, Areej, Murthy, Hemant, Almohareb, Fahad, Hashmi, Shahrukh K., Cappelli, Barbara, Alahmari, Ali, Scigliuolo, Graziana Maria, Kassim, Adetola, Aljurf, Mahmoud und Kharfan-Dabaja, Mohamed A. (2021) Systematic Review/Meta-Analysis on Efficacy of Allogeneic Hematopoietic Cell Transplantation in Sickle Cell Disease: An International Effort on Behalf of the Pediatric Diseases Working Party of European Society for Blood and Marrow Transplantation and the Sickle Cell Transplantation International Consortium. Transplantation and Cellular Therapy 27 (2), 167.e1-167.e12. Volltext nicht vorhanden.